MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Henry Schein medical sales lead to Street-beating Q1

Henry Schein medical sales lead to Street-beating Q1

By

Henry ScheinHenry Schein (NSDQ:HSIC) shares got a boost today on first-quarter results that topped the consensus forecast as medical sales boomed.

The Melville, N.Y.-based company posted profits of $130.3 million, or 91¢ per share, on sales of $2.4 billion for the three months ended March 28, 2020, for an 18.7% bottom-line gain on sales growth of 2.9%.

Adjusted to exclude one-time items, earnings per share were 94¢, 21¢ ahead of Wall Street, where analysts were looking for sales of $2.3 billion.

Henry Schein’s dental business took a 4.6% hit as COVID-19 pandemic is leading to the closures of dental practices except for emergency procedures. However, the company’s $800.7 million total in medical sales represented 17.1% growth year over year.

The company also implemented a payroll cost reduction plan with furloughs, reduced work hours, voluntary unpaid time off, suspension of the 401(k) match, and job reductions. Meanwhile, executives took pay cuts ranging from 10% to 100%, according to a news release.

“Due to the speed and severity of the COVID-19 health care and related economic crisis, this is one of the most trying moments in modern history for everyone,” Henry Schein chairman & CEO Stanley Bergman said in the news release. “We took swift and decisive action to reduce our cost structure to best position Henry Schein through this crisis and beyond. I have the utmost confidence in our business strategy, in our leadership team and in all of team Schein. Together we are making critical decisions to manage the company in the interest of all constituents – team Schein, customers, suppliers, investors and society – and in doing so, we are building value for the long-term.”

Henry Schein withdrew its 2020 financial guidance last month amid uncertainties caused by the COVID-19 pandemic.

HSIC shares were up 5.8% at $55.55 per share in early-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was up 1.4%.

In case you missed it

RSS From Medical Design & Outsourcing

  • Researchers tout biomaterials that can be ‘fine-tuned’ for medtech
    Researchers in the UK and U.S. are touting a new thermoplastic biomaterial capable of “fine-tuning” for use in soft tissue repair or bioelectronics. According to a news release, the material, which is a type of polyester, has been developed by a team at the University of Birmingham (UK) and Duke University (U.S.) for use in… […]
  • HHS could make permanent pandemic-related exemptions for some devices
    HHS has used the Trump administration’s waning days to propose permanently exempting certain medical devices — including infusion pump controllers and fetal monitors — from the FDA 510(k) clearance process. In a notice published Jan. 15, 2021, in the Federal Register, the agency also listed seven types of patient examination gloves that it has decided… […]
  • Medtechs can’t set digital strategies aside – DTW Podcast
    Digital connectivity no longer belongs in the final slides of a medtech company’s pitch deck. In the latest DeviceTalks Weekly podcast, three leaders pushing for connected medical devices explain the need to incorporate data collection and monitoring functionality in new devices: Scott Huennekens, who advanced the “digital surgery” strategy when he helped launch Verb Surgical,… […]
  • Protolabs to acquire 3D Hubs for up to $330M
    Protolabs (NYSE: PRLB) today announced it plans to acquire Amsterdam-based 3D Hubs, an online manufacturing platform that provides engineers with on-demand access to a global network of approximately 240 manufacturing partners. The transaction creates a comprehensive digital manufacturing offer for custom parts, expanding Protolabs’ breadth of capabilities as well as adding a broader offering of pricing and… […]
  • These medtech stocks performed the best in 2020
    While 2020 did not go as planned for anyone, with the twists and turns came opportunities for medtech companies to power forward. Innovations came both as a result of the COVID-19 pandemic and perhaps in spite of the challenges brought on by the virus, highlighted by the increased efforts to produce vaccines and testing while… […]
  • Covestro tests plastics against high-strength hospital disinfectants
    Covestro announced that it recently teamed with disinfectant manufacturer Metrex to test six different Covestro polycarbonate materials against three of Metrex’s products, which are widely used throughout the healthcare industry. As is customary for rapidly assessing the compatibility of plastics to disinfectants, test specimens were pre-strained and underwent several wipe-and-dry cycles with Metrex disinfectants to… […]
  • Integer expands N.Y. battery plant
    Integer announced today that it recently broke ground on an expansion of its Alden, N.Y., facility to accommodate new equipment that will substantially increase the plant’s production capacity for rechargeable Xcellion lithium-ion batteries. The project kicked off in mid-December 2020 and will add both production equipment and a build-out of Integer’s existing facility. The company… […]
  • Diversified Plastics adds high-efficiency vertical presses
    Diversified Plastics (DPI) announced that it recently installed six all-electric vertical injection molding presses. These presses will join DPI’s existing assemblage of vertical presses and provide increased production capacity to meet growing demand from medical device and other original equipment manufacturers (OEMs). DPI uses vertical presses for over-molding and insert-molding, capabilities often required for medical… […]
  • Traco Power expands power supply line for portable medical equipment
    Traco Power announced that it has expanded its TPP 450 high-density 3×5 power supply series. The series now offers Protection Class II models (TPP 450BA-M Open-Frame Models and TPP 450B-M Enclosed with Fan Models), designed for non-stationary requirements where connection to ground is not possible. Key approvals on the original series remain on the expanded… […]
  • Reflow Medical launches low-profile reinforced support catheters
    Reflow Medical today announced it has launched its Reflow Spex Low Profile reinforced support catheters. The Spex LP catheters are designed to provide the lowest profile tip to access and cross the tightest and most complex lesions with a supportive system. They come in 0.014 in. and 0.018 in. sizes and can be combined with… […]
  • Former CDER head Woodcock to lead FDA for now
    FDA veteran Dr. Janet Woodcock has been tapped as interim FDA commissioner by the Biden administration, according to published reports. An article by BioCentury also said that former FDA commissioner David Kessler, who had been mentioned as a possible replacement for current commissioner Stephen Hahn, will be a consultant to the agency but will not… […]